Article
FeNO as biomarker for asthma phenotyping and management.
Allergy and asthma proceedings - 1 Jan 2000
Ricciardolo Fabio L M, Sorbello Valentina, Ciprandi Giorgio
Abstract excerpt
The current review aims to revisit literature on exhaled nitric oxide (FeNO) in asthma phenotyping and management to clarify the utility of this test in clinical practice. It is increasingly evident that multiple profiles characterize asthma as a complex disease for which is necessary to find tools able to discriminate among these phenotypes to achieve the best therapeutic strategy for all asthmatic patients....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
